103 related articles for article (PubMed ID: 6191132)
21. Facilitation of reentry by lidocaine in canine myocardial infarction.
Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
Am Heart J; 1994 Feb; 127(2):345-52. PubMed ID: 7507635
[TBL] [Abstract][Full Text] [Related]
22. Effects of lignocaine on intramyocardial conduction in nonischaemic and ischaemic canine myocardium.
Levites R; Haft JJ; Venkatachalapathy D
Cardiovasc Res; 1976 Nov; 10(6):687-90. PubMed ID: 991167
[TBL] [Abstract][Full Text] [Related]
23. Effects of verapamil and lidocaine on changes in action potential characteristics and conduction time induced by combined hypoxia, hyperkalemia, and acidosis in canine ventricular myocardium.
Kimura S; Nakaya H; Kanno M
J Cardiovasc Pharmacol; 1982; 4(4):658-67. PubMed ID: 6181342
[TBL] [Abstract][Full Text] [Related]
24. Slow antegrade excitation and delayed retrograde activation through an "inexcitable zone": A basis for arrhythmia formation in infarcted myocardium ex vivo.
Patterson E; Scherlag BJ
J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1213-1222. PubMed ID: 28570022
[TBL] [Abstract][Full Text] [Related]
25. Effects of lidocaine on hypoxic and ischemic cardiac cells.
Lazzara R; Hope RR; El-Sherif N; Scherlag BJ
Am J Cardiol; 1978 May; 41(5):872-9. PubMed ID: 645595
[No Abstract] [Full Text] [Related]
26. Cardiac sympathetic nervous activity during myocardial ischemia, reperfusion and ventricular fibrillation in the dog--effects of intravenous lidocaine.
Aidonidis I; Brachmann J; Seller H; Demowsky K; Czachurski J; Kübler W
Cardiology; 1992; 80(3-4):196-204. PubMed ID: 1511466
[TBL] [Abstract][Full Text] [Related]
27. Acute effects of lidocaine on repolarization and conduction in patients with coronary artery disease.
Endresen K; Amlie JP
Clin Pharmacol Ther; 1989 Apr; 45(4):387-95. PubMed ID: 2702796
[TBL] [Abstract][Full Text] [Related]
28. Absence of supernormal conduction in canine myocardium.
Carson DL; Dresel PE
Can J Physiol Pharmacol; 1983 Mar; 61(3):207-12. PubMed ID: 6839217
[TBL] [Abstract][Full Text] [Related]
29. Relationship between an arrhythmogenic action of lidocaine and its effects on excitation patterns in acutely ischemic porcine myocardium.
Carson DL; Cardinal R; Savard P; Vasseur C; Nattel S; Lambert C; Nadeau R
J Cardiovasc Pharmacol; 1986; 8(1):126-36. PubMed ID: 2419674
[TBL] [Abstract][Full Text] [Related]
30. Actions of lidocaine on transmembrane potentials of subendocardial Purkinje fibers surviving in infarcted canine hearts.
Allen JD; Brennan FJ; Wit AL
Circ Res; 1978 Sep; 43(3):470-81. PubMed ID: 679429
[TBL] [Abstract][Full Text] [Related]
31. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
[TBL] [Abstract][Full Text] [Related]
32. Rate-dependent effects of lidocaine on His-Purkinje conduction in the intact neonatal heart--characterization and amplification by N-acetylprocainamide.
Dise TL; Stolfi A; Clarkson CW; Pickoff AS
J Pharmacol Exp Ther; 1991 Nov; 259(2):535-42. PubMed ID: 1719192
[TBL] [Abstract][Full Text] [Related]
33. T wave changes persisting after ventricular pacing in canine heart are altered by 4-aminopyridine but not by lidocaine. Implications with respect to phenomenon of cardiac 'memory'.
del Balzo U; Rosen MR
Circulation; 1992 Apr; 85(4):1464-72. PubMed ID: 1555287
[TBL] [Abstract][Full Text] [Related]
34. Effects of nifedipine on conduction delay during ventricular myocardial ischemia and reperfusion.
Fujimoto T; Peter T; Hamamoto H; McCullen AE; Mandel WJ
Am Heart J; 1981 Jul; 102(1):45-52. PubMed ID: 7246412
[TBL] [Abstract][Full Text] [Related]
35. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
[TBL] [Abstract][Full Text] [Related]
36. Overdrive suppression of conduction in the canine His-Purkinje system after occlusion of the anterior septal artery.
Takahashi N; Gilmour RF; Zipes DP
Circulation; 1984 Sep; 70(3):495-505. PubMed ID: 6744553
[TBL] [Abstract][Full Text] [Related]
37. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction.
Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K
Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339
[TBL] [Abstract][Full Text] [Related]
38. Sequential unipolar strength-interval curves and conduction times during myocardial ischemia and reperfusion in the dog.
Levine HJ; Avitall B; Pauker SG; Naimi S
Circ Res; 1978 Jul; 43(1):63-72. PubMed ID: 657459
[TBL] [Abstract][Full Text] [Related]
39. Differing electrophysiologic effects of slow response inhibiting agents manganese and verapamil on ischemic, infarcted and normal tissue in situ.
Kupersmith J; Cohen R
J Pharmacol Exp Ther; 1980 Nov; 215(2):394-400. PubMed ID: 7441504
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of lignocaine and hypercalcaemia on anisotropic conduction and reentry in the ischaemically damaged canine ventricle.
Hélie F; Cossette J; Vermeulen M; Cardinal R
Cardiovasc Res; 1995 Mar; 29(3):359-72. PubMed ID: 7781010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
